Nuvation Bio (NUVB) Non Operating Income (2020 - 2026)

Nuvation Bio (NUVB) has reported Non Operating Income for 7 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non Operating Income fell 73.72% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $4.2 million (down 83.29% YoY), while the FY2025 annual figure was $8.4 million, down 65.83% from the prior year.
• Non Operating Income improved to $1.5 million in Q1 2026 per NUVB's latest filing, from -$2.6 million in the prior quarter.
• Across five years, Non Operating Income topped out at $7.9 million in Q2 2024 and bottomed at -$2.6 million in Q4 2025.
• Historically, Non Operating Income has averaged $4.4 million across 5 years, with a median of $4.8 million in 2023.
• Annual changes were most pronounced in 2022 — Non Operating Income soared 8313.41% — and 2025, when it sank 156.82%.
• Nuvation Bio's Non Operating Income stood at $3.5 million in 2022, then soared by 101.83% to $7.0 million in 2023, then sank by 36.16% to $4.5 million in 2024, then tumbled by 156.82% to -$2.6 million in 2025, then surged by 159.33% to $1.5 million in 2026.
• Business Quant data shows NUVB's Non Operating Income at $1.5 million in Q1 2026, -$2.6 million in Q4 2025, and $642000.0 in Q3 2025.